Диссертация (1139557), страница 46
Текст из файла (страница 46)
Diagnostic accuracyof presepsin (sCD14-ST) as a biomarker of infection and sepsis in the emergency department// Clin. Chim. Acta. – 2017. - Jan; 464. – Р. 6-11.115. Hakuno D., Fukuda K. Role of anti-angiogenic factor chondromodulin-I for maintaining cardiac valvular function// Clin. Calcium. – 2007. - Mar;17(3). - Р.
361-372.116. Hall C. Essential biochemistry and physiology of NT-pro-BNP// Eur. J. of Heart.Fail. – 2004. – Mar 15;6(3). – P. 257–260.117. Harutyunyan M.J., Mathiasen A.B., Winkel P. et al. High-sensitivity C-reactiveprotein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial// Scand.
J. Clin. Lab. Invest.– 2011. - Feb;71(1). – Р. 52-62.118. He Q., LaPointe M.C. Interleukin-1beta regulation of the human brain natriureticpeptide promoter involves Ras-, Rac-, and p38 kinase- dependent pathways in cardiac305myocytes// Hypertension. – 1999. - Jan;33(1 Pt 2) – Р. 283-289.119. Heiro M., Helenius H., Sundell J. et.al. Utility of serum C-reactive protein in assessing the outcome of infective endocarditis// Eur.
Heart J. – 2005. - Sep; 26(18) –Р.1873.120. Hirano T., Yasukawa K., Harada H. et al. Complementary DNA for a novel humaninterleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin// Nature. –1986. - Nov 6-12;324(6092). - Р.73–76.121. Hollegaard M.V., Bidwell J.L. Cytokine gene polymorphism in human disease: online databases, Supplement 3// Genes. Immun. – 2006.
– Vol. 7, No 4. – P. 269-276.122. Htwe T.H., Khardori N.M. Cardiac emergencies: infective endocarditis, pericarditis and myocarditis// Med. Clin. North. Am. – 2012. - Nov 96(6). – Р. 1149-1169.123. Jacobs J.W., Lund P.K., Potts J.T. et al. Procalcitonin is a glycoprotein// J. Biol. Chem. –1981. – Mar 25; Vol. 256(6). – P. 2803-2807.124. Januzzi J.L.Jr., Filippatos G., Nieminen M., Gheorghiade M.
Troponin elevation inpatients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section// Eur. Heart J. – 2012. - Sep;33(18). Р. 2265–2271.125. Jeong H.S., Lee T.H., Bang C.H. et al. Risk factors and outcomes of sepsis-inducedmyocardial dysfunction and stress-induced cardiomyopathy in sepsis or septic shock: Acomparative retrospective study// Medicine (Baltimore). - 2018 - Mar;97(13). - e0263.126. Kaczka K., Mikosiński S., Fendler W. et al. Calcitonin and procalcitonin in patientswith medullary thyroid cancer or bacterial infection// Adv. Clin.
Exp. Med. Off Organ.Wroclaw Med. Univ. – 2012. – Vol. 21 (2) – P. 169–178.127. Kahveci G., Bayrak F., Mutlu B. et al. Prognostic value of N-terminal pro-B-typenatriuretic peptide in patients with active infective endocarditis// Am. J. Cardiol. – 2007.– May 15; Vol. 99(10). – P. 1429-1433.128. Karabulut A., Kaplan A., Aslan C. et al. The association between NT-proBNP levels, functional capacity and stage in patients with heart failure// Acta Cardiol. – 2005. –Dec; Vol. 60(6). – P. 631-638.129. Kiichiro Yano, Patricia C.
Liaw, Janet M. Mullington et al. Vascular endothelial306growth factor is an important determinant of sepsis morbidity and mortality// Jem. – 2006.- June 12; Vol. 203(6). – Р. 1447–1458.130. Kim J.S., Kim K.D., Na H.S. et al. Tumor necrosis factor-α and interleukin-1β expression pathway induced by Streptococcus mutans in macrophage cell line RAW 264.7//Mol. Oral. Microbiol. – 2012. - Jun;27(3). - Р.149-159.131. Kimura A., Kishimoto T. IL-6: Regulator of Treg/Th17 balance// Eur. J. Immunol.- 2010.
- Jul;40(7) - Р. 1830–1835.132. Klouche K., Cristol J.P., Devin J. et al. Diagnostic and prognostic value of solubleCD14 subtype (Presepsin) for sepsis and community-acquired pneumonia in ICU patients// Ann Intensive Care. – 2016. - Dec;6(1). – Р. 59.133. Knudsen J.B., Fuursted K., Petersen E. et al.
Procalcitonin in 759 patients clinicallysuspected of infective endocarditis// Am. J. Med. – 2010 - Dec;123(12) - Р. 1121–1127.134. Koizumi Y., Shimizu K., Shigeta M. et al. Plasma presepsin level is an early diagnostic marker of severe febrile neutropenia in hematologic malignancy patients// BMCInfect. Dis. – 2017. - Jan 5;17(1). – Р. 27.135.
Korn T., Bettelli E., Oukka M. et al. IL-6 and Th17 cells// Annu Rev. Immunol. 2009. – Vol. 27. – Р. 485–517.136. Koubek R. Infective endocarditis in Tabor district in years 2009-2013// Vnitr. Lek.– 2014. - Oct;60(10). - Р. 827-831.137. Kumar S., Ingle H., Prasad D.V.R. et al. Recognition of bacterial infection by innate immune sensors// Crit.
Rev. Microbiol. – 2013. - Aug;39(3). – Р.229–246.138. Kuwahara K., Saito Y., Harada M. et al. Involvement of cardiotrophin-1 in cardiacmyocyte-nonmyocyte interactions during hypertrophy of rat cardiac myocytes in vitro//Circulation. – 1999. – Sep 7;100(10). – Р. 1116-1124.139. Kyung Chan Park, David C. Gaze, Paul O Collinson, Michael S. Marber Cardiactroponins: from myocardial infarction to chronic disease// Cardiovascular Research. –2017.
- 1 December, vol. 113 (14). – Р. 1708–1718.140. Lamas C.C., Eykyn S.J. Bicuspid aortic valve- a silent danger: analysis of 50 casesof infective endocarditis// Clin. Inf. Dis. – 2000. - Vol.30. - P.336-341.307141. Landesberg G., Gilon D., Meroz Y. et al. Diastolic dysfunction and mortality insevere sepsis and septic shock// Eur. Heart. J. - 2012.
– Vol. 33(7). -P. 895-903.142. Lankeit M., Jiménez D., Kostrubiec M. et al. Validation of N-terminal pro-brainnatriuretic peptide cut-off values for risk stratification of pulmonary embolism// Eur.Respir. J. – 2014. - Jun;43(6). - 1669-1677.143. Le Moullec J.M., Jullienne A., Chenais J.
et al. The complete sequence of humanpreprocalcitonin// FEBS Lett. – 1984. – Feb 13; Vol. 167(1). – P. 93-97.144. Leli C., Ferranti M., Moretti A. et al. Procalcitonin levels in gram-positive, gramnegative, and fungal bloodstream infections// Dis Markers. – 2015. - 701480.145. Leli C., Ferranti M., Marrano U. et al. Diagnostic accuracy of presepsin (sCD14ST) and procalcitonin for prediction of bacteraemia and bacterial DNAaemia in patientswith suspected sepsis// J.
Med. Microbiol. – 2016. - Aug;65(8). - 713-719.146. Levy R. J., Piel D. A., Acton P. D. et al. Evidence of myocardial hibernation in theseptic heart// Critical Care Medicine. – 2005. – 33 (12). – Р. 2752–2756.147. Li L., Wang H., Wang L. et al. Changing profile of infective endocarditis: a clinicopathologic study of 220 patients in a single medical center from 1998 through 2009//Tex.
Heart Inst. J. – 2014. - Oct 1;41(5). – Р. 491-498.148. Limper M., de Kruif M.D., Duits, A.J. et al. The diagnostic role of procalcitoninand other biomarkers in discriminating infectious from non-infectious fever// J. Infect. –2010. - Jun;60(6). – Р. 409–416.149. Lin J., Li Z., Zheng Y. et al. Elevated Presepsin Levels are Associated with Severityand Prognosis of Severe Acute Pancreatitis// Clin. Lab.
– 2016. - Sep 1;62(9). – Р. 16991708.150. Liquori M.E., Christenson R.H., Collinson P.O., Defilippi C.R. Cardiac biomarkersin heart failure// Clin. Biochem. – 2014. - Apr;47(6). - Р. 327–337.151. Liu J., Marino M.W., Wong G. et al. TNF is a potent anti-inflammatory cytokinein autoimmune- mediated demyelination// Nat. Med. – 1998. – Vol. 4.
– P. 78–83.152. Luchner A., Burnett J.C.Jr., Jougasaki M. et al. Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: evidence from a population-based study//J.Am. Coll. Cardiol. – 1998. – Dec;32(7). – P. 1839-1844.308153. Luchner A., Hengstenberg C., Lowel H. et.al. N-terminal pro-brain natriuretic peptide after myocardial infarction: a marker of cardio-renal function// Hypertension. – 2002.– Vol. 39. – P. 99–104.154. Ma C.S., Deenick E.K., Batten M., Tangye S.G.
The origins, function, and regulation of T follicular helper cells// J. Exp. Med. – 2012. - Jul 2;209(7). - Р.1241–1253.155. Maeder M., Fehr T., Rickli H., Ammann P Sepsis-associated myocardialdysfunction: diagnostic and prognostic impact of cardiac troponins and natriureticpeptides// Chest. – 2006. - May;129(5). – Р.1349-1366.156. Maharaj A.S.L., D’Amore P.A. Roles for VEGF in adult// Microvasc.